Products
Companies
News
About
About
Add your product
Contact
Newsletter
×
Subscribe to our monthly newsletter
Subscribe
Products
JPC-01K
JPC-01K
JLK Inc.
JPC-01K is an AI medical system that detects the area of prostate cancer using multiparametric MR images. The system is based on artificial neural networks to analyze the MR images of the prostate cancer patients. The system uses multiparametric MR images, T2, DWI, and DCE, as input and visualizes the location of the prostate cancer and their probability.
Information source:
Vendor
Last updated:
July 1, 2020
General Information
Technical Specifications
Regulatory
Market
Evidence
General Information
General
Product name
JPC-01K
Company
JLK Inc.
Subspeciality
Abdomen
Modality
MR
Disease targeted
Prostate cancer
Key-features
Prostate cancer detection
Suggested use
During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion
Technical Specifications
Data characteristics
Population
all prostate MR
Input
multi sequence MR images (T2, DWI(Diffusion Weighted Image), DCE(Dynamic Contrast Enhanced))
Input format
DICOM, JPG
Output
Heatmap overlay, the probability of prostate cancer
Output format
UI, Report
Technology
Integration
Stand-alone third party application, Stand-alone webbased
Deployment
Locally on dedicated hardware, Cloud-based, Hybrid solution
Trigger for analysis
On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time
10 - 60 seconds
Regulatory
Certification
CE
Certified, Class I
, MDD
FDA
No or not yet
Intended Use Statements
Intended use (according to CE)
Market
Market presence
On market since
04-2019
Distribution channels
Countries present (clinical, non-research use)
2
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Pay-per-use, Subscription
Based on
Number of users, Number of installations
Evidence
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers